Buy Dishman Pharma, Raj TV, PVR: Ashish Kapur

In CNBC-TV18's popular show Bull's Eye, Ashish Kapur, Investshoppe shares trading strategy of the day.

Buy Dishman Pharma with a target of Rs 108 and stop loss of Rs 97. This is a company which is very well established in the contract research and manufacturing space. The company has been doing very well and going forward. We believe that various positive triggers in the form of a number of generic APIs which the company is launching. Also the company is planning to get out of the SEZ business in selling off its land to an infrastructure company. This should result in a huge amount of cash inflow. Buy Raj TV with a target of Rs 247 and stop loss of Rs 218. Raj TV is a very well established player in the southern market and has the biggest market share in the Tamil Nadu market for television. Going by the trends we feel that the penetration is set to increase with digitization and other factors. Being a very well established player Raj TV is set to gain. The company has been performing very well and management is confident of a very good growth rate going forward. Buy Shree Ganesh Jewellery with a target of Rs 115 and stop loss of Rs 104. This Kolkata based company is expanding rapidly in the retail segment of jewellery business. Given the kind of consumer disposable income and the kind of interest shown earlier in similar kind of exercise done by Gitanjali we are confident that this company would also do well going forward. The company has taken various initiatives like gold vending machines and various forms of jewellery which is going to be displayed in various retail outlets. Buy PVR with a target of Rs 240 and stop loss of Rs 217. Given the kind of disposable income growth in India and the kind of interest towards cinema we feel that this company is in a very speed spot. It is planning to add another 160 screens this fiscal and altogether the company is on a very good growth path. Also there are other initiative which is the business is doing fairly well. Given all this we feel that the stock is quite undervalued at the current price.